Subcutaneous REGEN-COV antibody administration in a community pharmacy

BACKGROUND: REGEN-COV is a non-Food and Drug Adminstration approved monoclonal antibody combination of casirivimab/imdevimab. Casirivimab/imdevimab was previously used for the treatment of SARS-CoV-2 infection (COVID-19), under an emergency use authorization, and has demonstrated a reduction in hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Dougherty, Tyler S., McBride, Jimmy, Barnett, Carol L., Gabriel, Wendy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Pharmacists Association®. Published by Elsevier Inc. 2023
Materias:
Advances in Pharmacy Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824949/
https://www.ncbi.nlm.nih.gov/pubmed/36710148
http://dx.doi.org/10.1016/j.japh.2023.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824949/
https://www.ncbi.nlm.nih.gov/pubmed/36710148
http://dx.doi.org/10.1016/j.japh.2023.01.002

Ejemplares similares